Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX)’s Basic Consolidated EPS Came In At $-1.1852

0

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) posted annual consolidated EPS of $-1.1852 for the period ended 2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-1.1852.

Basic EPS from continuing operations

The company’s basic EPS from continuing operations for the annual period ended 2015-12-31 came in at $-1.1852 while basic EPS from continuing operations for the three-month period to 2015-12-31 was$-1.1852.

EPS contribution from parent

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) received $-1.1852 basic EPS contribution from its parent company in the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, the parent company contributed EPS of $-1.1852.

Basic net EPS

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) posted basic net EPS of $-1.19 for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, the company posted basic net EPS of $-1.19.

Consolidated diluted EPS

The company’s consolidated diluted EPS for the period ended 2015-12-31 was $-1.1852 while consolidated diluted EPS was $-1.1852 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS from continuing operation for the annual period ended 2015-12-31 was $-1.1852. As for the quarter, diluted EPS from continuing operations for the three-month ended 2015-12-31 stood at $-1.1852.

Net diluted EPS

Net diluted EPS was $-1.19 for the annual period ended 2015-12-31. But net diluted EPS for the quarterly period ended 2015-12-31 stood at $-1.19.

Diluted EPS from parent

From the parent company, Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) received diluted EPS of $-1.1852

For the annual period ended 2015-12-31, diluted EPS from Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX)’s parent company was$-1.1852. But for the quarter period ended 2015-12-31, diluted EPS contribution from the parent company was $-1.1852.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX)’s net basic EPS for the annual period ended 2015-12-31 was $-1.19 and for the quarter period ended 2015-12-31 it was $-1.19.

For the annual period ended 2015-12-31, the company had average basic shares outstanding of 103.898 while basic shares outstanding were 103.898 for the quarter period ended 2015-12-31.

The company’s diluted shares outstanding was 103.898 for the annual period ended 2015-12-31 is 103.898. That compared with 103.898 diluted shares outstanding for the quarter period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 6 times, 1 visits today)